In a report released on July 9, from UBS maintained a Buy rating on InSilico Medicine Cayman TopCo, with a price target of HK$77.00. The company’s shares closed yesterday at HK$39.84.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Currently, the analyst consensus on InSilico Medicine Cayman TopCo is a Moderate Buy with an average price target of HK$77.00.
